Language Settings
Select Website Language
newshunt
newshunt

Pharma growth: AstraZeneca profit surges 77% to $2.53 bn in Q3; US expansion and cancer drugs power strong results

6 months ago

AstraZeneca reported a significant 77% surge in quarterly net profit, reaching $2.53 billion, driven by strong US growth and robust sales of its cancer drugs. The pharmaceutical giant's revenue climbed 12% to $15.2 billion, with oncology treatments now comprising nearly 44% of its total income. This performance underscores the company's strategic focus on expanding its US operations and manufacturing footprint.
Click here to Read More
Previous Article
Global leaders to gather for 17th GRIHA Summit on 'Innovate to Act for a Climate Resilient World'
Next Article
LIC Q2 results: Profit up 31% YoY to Rs 10,098 cr; premium income grows 5.5% as AUM, solvency ratio improve

Related Business Updates:

Are you sure? You want to delete this comment..! Remove Cancel

Comments (0)

    Leave a comment